Search Results - "Alonso García, Angeles"

Polypill Strategy in Secondary Cardiovascular Prevention by Castellano, Jose M., Pocock, Stuart J., Bhatt, Deepak L., Quesada, Antonio J., Owen, Ruth, Fernandez-Ortiz, Antonio, Sanchez, Pedro L., Marin Ortuño, Francisco, Vazquez Rodriguez, Jose M., Domingo-Fernández, Alexandra, Lozano, Iñigo, Roncaglioni, Maria C., Baviera, Marta, Foresta, Andreana, Ojeda-Fernandez, Luisa, Colivicchi, Furio, Di Fusco, Stefania A., Doehner, Wolfram, Meyer, Antje, Schiele, François, Ecarnot, Fiona, Linhart, Aleš, Lubanda, Jean-Claude, Barczi, Gyorgy, Merkely, Bela, Ponikowski, Piotr, Kasprzak, Marta, Fernandez Alvira, Juan M., Andres, Vicente, Bueno, Hector, Collier, Timothy, Van de Werf, Frans, Perel, Pablo, Rodriguez-Manero, Moises, Alonso Garcia, Angeles, Proietti, Marco, Schoos, Mikkel M., Simon, Tabassome, Fernandez Ferro, Jose, Lopez, Nicolas, Beghi, Ettore, Bejot, Yannick, Vivas, David, Cordero, Alberto, Ibañez, Borja, Fuster, Valentin

“…Among patients with recent MI, therapy with a polypill containing aspirin, ramipril, and atorvastatin led to a lower incidence of major adverse cardiovascular…”
Get full text

Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion by Zannad, Faiez, Stough, Wendy Gattis, Lipicky, Raymond J., Tamargo, Juan, Bakris, George L., Borer, Jeffrey S., Alonso García, Maria de los Angeles, Hadjadj, Samy, Koenig, Wolfgang, Kupfer, Stuart, McCullough, Peter A., Mosenzon, Ofri, Pocock, Stuart, Scheen, André J., Sourij, Harald, Van der Schueren, Bart, Stahre, Christina, White, William B., Calvo, Gonzalo

“…The Food and Drug Administration issued guidance for evaluating the cardiovascular risk of new diabetes mellitus drugs in 2008. Accumulating evidence from…”
Get full text

Implications of geographical variation on clinical outcomes of cardiovascular trials by Mentz, Robert J., MD, Kaski, Juan-Carlos, DSc, MD, Dan, Gheorghe-Andrei, MD, PhD, Goldstein, Sidney, MD, Stockbridge, Norman, MD, PhD, Alonso-Garcia, Angeles, MD, Ruilope, Luis M., MD, Martinez, Felipe A., MD, Zannad, Faiez, MD, Pitt, Bertram, MD, Fiuzat, Mona, PharmD, O'Connor, Christopher M., MD

“…Cardiovascular clinical trials are increasingly conducted globally as a means to reduce costs, expedite timelines, provide broad applicability, and satisfy…”
Get full text

What can heart failure trialists learn from oncology trialists? by Zannad, Faiez, Cotter, Gad, Alonso Garcia, Angeles, George, Suzanne, Davison, Beth, Figtree, Gemma, Prasad, Krishna, Rockhold, Frank, Schilsky, Richard L, Stockbridge, Norman, Pitt, Bertram, Butler, Javed

“…Globally, there has been little change in mortality rates from cardiovascular (CV) diseases or cancers over the past two decades (1997–2018). This is…”
Get full text

Guidelines on the management of stable angina pectoris: executive summary by Fox, K, Angeles, Alonso Garcia M, Ardissino, D, Buszman, P, Camici, PG, Crea, F, Daly, C, De, Backer G

Get full text

Two-year outcomes post-discharge in Asian patients with acute coronary syndrome: Findings from the EPICOR Asia study by Huo, Yong, Lee, Stephen W.-L., Sawhney, Jitendra P.S., Kim, Hyo-Soo, Krittayaphong, Rungroj, Pocock, Stuart J., Nhan, Vo T., Alonso-Garcia, Ángeles, Chin, Chee Tang, Jiang, Jie, Jan, Stephen, Vega, Ana M., Hayashi, Nobuya, Ong, Tiong Kiam

“…Approximately half of cases of cardiovascular disease (CVD) worldwide occur in Asia, with acute coronary syndrome (ACS) a leading cause of mortality. Long-term…”
Get full text

Role of Payers in the Development of Cardiovascular Therapeutics: Misalignment Between Approval and Reimbursement by Zannad, Faiez, Alonso Garcia, Maria de Los Angeles, Borer, Jeffrey S, Stough, Wendy Gattis, Clutton-Brock, Thomas, Rosenberg, Yves, Packer, Milton

“…Regulators and payers have contrasting priorities that can lead to divergent decisions and delays in patient access to new treatments. Those involved in…”
Get full text

Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary by Bueno, Héctor, de Graeff, Pieter, Richard-Lordereau, Isabelle, Emmerich, Joseph, Fox, Keith AA, Friedman, Carola P, Gaudin, Christophe, El-Gazayerly, Amany, Goldman, Samantha, Hemmrich, Melanie, Henderson, Robert A, Himmelmann, Anders, Irs, Alar, Jackson, Neville, James, Stefan K, Katus, Hugo A, Laslop, Andrea, Laws, Ian, Mehran, Roxana, Ong, Seleen, Prasad, Krishna, Roffi, Marco, Rosano, Giuseppe MC, Rose, Martin, Sinnaeve, Peter R, Stough, Wendy Gattis, Thygesen, Kristian, Van de Werf, Frans, Varin, Claire, Verheugt, Freek WA, de los Angeles Alonso García, Maria

“…Regulatory authorities interpret the results of randomized controlled trials according to published principles. The European Medicines Agency (EMA) is planning…”
Get full text

Long‐term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2‐year observations from the EPICOR Asia study by Zheng, Bo, Huo, Yong, Lee, Stephen W.‐L., Sawhney, Jitendra P. S., Kim, Hyo‐Soo, Krittayaphong, Rungroj, Pocock, Stuart J., Nhan, Vo T., Alonso Garcia, Angeles, Chin, Chee Tang, Jiang, Jie, Jan, Stephen, Vega, Ana Maria, Hayashi, Nobuya, Ong, Tiong K.

“…Background Despite guideline recommendations, dual antiplatelet therapy (DAPT) is frequently used for longer than 1 year after an acute coronary syndrome (ACS)…”
Get full text

New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval by Zannad, Faiez, Rossignol, Patrick, Stough, Wendy Gattis, Epstein, Murray, de los Angeles Alonso Garcia, Maria, Bakris, George L, Butler, Javed, Kosiborod, Mikhail, Berman, Lance, Mebazaa, Alexandre, Rasmussen, Henrik S, Ruilope, Luis M, Stockbridge, Norman, Thompson, Aliza, Wittes, Janet, Pitt, Bertram

“…Abstract Hyperkalemia is a common clinical problem, especially in patients with chronic kidney disease, diabetes mellitus, or heart failure. Treatment with…”
Get full text

Rationale, Design, and Baseline Characteristics of the EPICOR Asia Study (Long‐tErm follow‐uP of antithrombotic management patterns In Acute CORonary Syndrome patients in Asia) by Huo, Yong, Lee, Stephen W.‐L., Sawhney, Jitendra P. S., Kim, Hyo‐Soo, Krittayaphong, Rungroj, Nhan, Vo T., Alonso‐Garcia, Angeles, Han, Ya Ling, Ge, Junbo, Chin, Chee Tang, Ong, Tiong K., Jan, Stephen, Itoh, Yohji, Vega, Ana Maria, Pocock, Stuart

“…ABSTRACT Background In‐hospital and postdischarge mortality for acute coronary syndromes (ACS) vary across Asia and remain generally poorer than globally. The…”
Get full text

Large streamlined trials in cardiovascular disease by Calvo, Gonzalo, McMurray, John J V, Granger, Christopher B, Alonso-García, Ángeles, Armstrong, Paul, Flather, Marcus, Gómez-Outes, Antonio, Pocock, Stuart, Stockbridge, Norman, Svensson, Anders, Van de Werf, Frans

Get full text

Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology by Horstkotte, Dieter, Follath, Ferenc, Gutschik, Erno, Lengyel, Maria, Oto, Ali, Pavie, Alain, Soler-Soler, Jordi, Thiene, Gaetano, von Graevenitz, Alexander, Priori, Silvia G, Garcia, Maria Angeles Alonso, Blanc, Jean-Jacques, Budaj, Andrzej, Cowie, Martin, Dean, Veronica, Deckers, Jaap, Fernández Burgos, Enrique, Lekakis, John, Lindahl, Bertil, Mazzotta, Gianfranco, Morais, João, Smiseth, Otto A, Vahanian, Alec, Delahaye, François, Parkhomenko, Alexander, Filipatos, Gerasimos, Aldershvile, Jan, Vardas, Panos

Get full text

Expert consensus document on β-adrenergic receptor blockers: The Task Force on Beta-Blockers of the European Society of Cardiology by López-Sendó, José, Swedberg, Karl, McMurray, John, Tamargo, Juan, Maggioni, Aldo P, Dargie, Henry, Tendera, Michal, Waagstein, Finn, Kjekshus, Jan, Lechat, Philippe, Christian Torp Pedersen, Priori, Silvia G, Maria Angeles Alonso García, Blanc, Jean-Jacques

Get full text

Guidelines on the management of stable angina pectoris: executive summary : The task force on the management of stable angina pectoris of the european society of cardiology by FOX, Kim, ARDISSINO, Diego, MORAIS, Joao, PEPPER, John, SECHTEM, Udo, SIMOONS, Maarten, THYGESEN, Kristian, BUSZMAN, Pawel, CAMICI, Paolo G, CREA, Filippo, DALY, Caroline, DE BACKER, Guy, HJEMDAHL, Paul, LOPEZ-SENDON, José, MARCO, Jean

Get full text

Guidelines on the management of stable angina pectoris. Executive summary by Fox, Kim, García, María Angeles Alonso, Ardissino, Diego, Buszman, Pawel, Camici, Paolo G, Crea, Filippo, Daly, Caroline, de Backer, Guy, Hjemdahl, Paul, López-Sendón, José, Morais, João, Pepper, John, Sechtem, Udo, Simoons, Maarten, Thygesen, Kristian

Get full text

ESC Guidelines on the management of cardiovascular diseases during pregnancy by Regitz-Zagrosek, Vera, Blomstrom Lundqvist, Carina, Borghi, Claudio, Cifkova, Renata, Ferreira, Rafael, Foidart, Jean-Michel, Gibbs, J. Simon R., Gohlke-Baerwolf, Christa, Gorenek, Bulent, Iung, Bernard, Kirby, Mike, Maas, Angela H. E. M., Morais, Joao, Nihoyannopoulos, Petros, Pieper, Petronella G., Presbitero, Patrizia, Roos-Hesselink, Jolien W., Schaufelberger, Maria, Seeland, Ute, Torracca, Lucia, Bax, Jeroen, Auricchio, Angelo, Baumgartner, Helmut, Ceconi, Claudio, Dean, Veronica, Deaton, Christi, Fagard, Robert, Funck-Brentano, Christian, Hasdai, David, Hoes, Arno, Knuuti, Juhani, Kolh, Philippe, McDonagh, Theresa, Moulin, Cyril, Poldermans, Don, Popescu, Bogdan A., Reiner, Zeljko, Sechtem, Udo, Sirnes, Per Anton, Torbicki, Adam, Vahanian, Alec, Windecker, Stephan, Baumgartner, Helmut, Deaton, Christi, Aguiar, Carlos, Al-Attar, Nawwar, Garcia, Angeles Alonso, Antoniou, Anna, Coman, Ioan, Elkayam, Uri, Gomez-Sanchez, Miguel Angel, Gotcheva, Nina, Hilfiker-Kleiner, Denise, Kiss, Robert Gabor, Kitsiou, Anastasia, Konings, Karen T. S., Lip, Gregory Y. H., Manolis, Athanasios, Mebaaza, Alexandre, Mintale, Iveta, Morice, Marie-Claude, Mulder, Barbara J., Pasquet, Agnès, Price, Susanna, Priori, Silvia G., Salvador, Maria J., Shotan, Avraham, Silversides, Candice K., Skouby, Sven O., Stein, Jörg-Ingolf, Tornos, Pilar, Vejlstrup, Niels, Walker, Fiona, Warnes, Carole

Get full text

Expert consensus document on β-adrenergic receptor blockers by López-Sendó, José, Swedberg, Karl, McMurray, John, Tamargo, Juan, Maggioni, Aldo P., Dargie, Henry, Tendera, Michal, Waagstein, Finn, Kjekshus, Jan, Lechat, Philippe, Pedersen, Christian Torp, Priori, Silvia G., Alonso García, Maria Angeles, Blanc, Jean-Jacques, Budaj, Andrzej, Cowie, Martin, Dean, Veronica, Deckers, Jaap, Fernandez Burgos, Enrique, Lekakis, John, Lindahl, Bertil, Mazzotta, Gianfranco, McGregor, Keith, Morais, João, Oto, Ali, Smiseth, Otto A., Alonso García, Maria Angeles, Ardissino, Diego, Avendano, Cristina, Lundqvist, Carina Blomström, ment, Denis Clé, Drexler, Helmut, Ferrari, Roberto, Fox, Keith A., Julian, Desmond, Kearney, Peter, Klein, Werner, ber, Lars Kö, Mancia, Giuseppe, Nieminen, Markku, Ruzyllo, Witold, Simoons, Maarten, Thygesen, Kristian, Tognoni, Gianni, Tritto, Isabella, Wallentin, Lars

Get full text

International differences in treatment effect: do they really exist and why? by Pocock, Stuart, Calvo, Gonzalo, Marrugat, Jaume, Prasad, Krishna, Tavazzi, Luigi, Wallentin, Lars, Zannad, Faiez, Alonso Garcia, Angeles

“…With the increasing globalization of clinical trials, the opportunity exists to explore potential geographic differences in treatment effect within any major…”
Get full text

Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements? by ZANNAD, Faiez, STOUGH, Wendy Gattis, ABADIE, Eric, ALONSO-GARCIA, Angeles, PITT, Bertram, POCOCK, Stuart J, SLEIGHT, Peter, CUSHMAN, William C, CLELAND, John G. F, MCMURRAY, John J. V, LONN, Eva, GELLER, Nancy L, WEDEL, Hans

“…Glycaemic control is an inadequate surrogate marker of cardiovascular event reduction in patients with type 2 diabetes. Clinical trials to date have been…”
Get full text